Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9586 |
High Similarity |
NPD8054 |
Approved |
0.9586 |
High Similarity |
NPD8053 |
Approved |
0.9401 |
High Similarity |
NPD8251 |
Approved |
0.9401 |
High Similarity |
NPD8252 |
Approved |
0.9401 |
High Similarity |
NPD8099 |
Discontinued |
0.9345 |
High Similarity |
NPD8156 |
Discontinued |
0.8693 |
High Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8441 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.8263 |
Intermediate Similarity |
NPD4584 |
Approved |
0.8208 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8054 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7989 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.7977 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7931 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7904 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7838 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7742 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7735 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7735 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7713 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7692 |
Intermediate Similarity |
NPD27 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD2563 |
Approved |
0.764 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7572 |
Intermediate Similarity |
NPD2420 |
Approved |
0.7572 |
Intermediate Similarity |
NPD2421 |
Approved |
0.7572 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7572 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7529 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7529 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4678 |
Approved |
0.75 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7473 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7443 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7443 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7391 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7345 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7345 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7345 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD6107 |
Approved |
0.7337 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7337 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7337 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4475 |
Approved |
0.731 |
Intermediate Similarity |
NPD2975 |
Approved |
0.731 |
Intermediate Similarity |
NPD2974 |
Approved |
0.731 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7309 |
Intermediate Similarity |
NPD8153 |
Approved |
0.7309 |
Intermediate Similarity |
NPD8152 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7287 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD6997 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7236 |
Intermediate Similarity |
NPD3837 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7231 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7231 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7214 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7214 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7047 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD4580 |
Approved |
0.72 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7175 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7167 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.715 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7119 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7104 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7098 |
Intermediate Similarity |
NPD2968 |
Approved |
0.7098 |
Intermediate Similarity |
NPD2971 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7065 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7062 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7052 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD6621 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7022 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.6989 |
Remote Similarity |
NPD7037 |
Approved |
0.6986 |
Remote Similarity |
NPD7827 |
Phase 1 |
0.6984 |
Remote Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD7479 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD1613 |
Approved |
0.6971 |
Remote Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD7493 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD7590 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD5976 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6954 |
Remote Similarity |
NPD6896 |
Approved |
0.6954 |
Remote Similarity |
NPD6895 |
Approved |
0.6952 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD4237 |
Approved |
0.6949 |
Remote Similarity |
NPD3060 |
Approved |
0.6944 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD4166 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD4873 |
Discontinued |
0.6927 |
Remote Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4585 |
Approved |
0.6915 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD1753 |
Discontinued |
0.6911 |
Remote Similarity |
NPD5938 |
Phase 3 |
0.6906 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD5090 |
Approved |
0.6902 |
Remote Similarity |
NPD7438 |
Suspended |
0.6902 |
Remote Similarity |
NPD5089 |
Approved |
0.6901 |
Remote Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.6898 |
Remote Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD4040 |
Phase 1 |
0.6884 |
Remote Similarity |
NPD7907 |
Approved |
0.6881 |
Remote Similarity |
NPD6284 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6872 |
Remote Similarity |
NPD2677 |
Approved |
0.6869 |
Remote Similarity |
NPD7291 |
Discontinued |
0.6868 |
Remote Similarity |
NPD7427 |
Discontinued |
0.6854 |
Remote Similarity |
NPD4162 |
Approved |
0.6851 |
Remote Similarity |
NPD7020 |
Approved |
0.6851 |
Remote Similarity |
NPD7019 |
Approved |
0.6845 |
Remote Similarity |
NPD7773 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.6836 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD7030 |
Discontinued |
0.6828 |
Remote Similarity |
NPD2978 |
Approved |
0.6828 |
Remote Similarity |
NPD2977 |
Approved |
0.6825 |
Remote Similarity |
NPD2904 |
Discontinued |
0.6821 |
Remote Similarity |
NPD7477 |
Discontinued |
0.6816 |
Remote Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD7125 |
Discontinued |
0.6813 |
Remote Similarity |
NPD7526 |
Approved |
0.6813 |
Remote Similarity |
NPD52 |
Approved |
0.6813 |
Remote Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.6813
|
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |